Biosynthesis of the <i>Caenorhabditis elegans</i> dauer pheromone

Rebecca A. Butcher(Harvard University), Justin R. Ragains(Harvard University), Weiqing Li(University of Washington), Gary Ruvkun(Harvard University), Jon Clardy(Harvard University), Ho Yi Mak(Stowers Institute for Medical Research)
Proceedings of the National Academy of Sciences
January 28, 2009
Cited by 178Open Access
Full Text

Abstract

To sense its population density and to trigger entry into the stress-resistant dauer larval stage, Caenorhabditis elegans uses the dauer pheromone, which consists of ascaroside derivatives with short, fatty acid-like side chains. Although the dauer pheromone has been studied for 25 years, its biosynthesis is completely uncharacterized. The daf-22 mutant is the only known mutant defective in dauer pheromone production. Here, we show that daf-22 encodes a homolog of human sterol carrier protein SCPx, which catalyzes the final step in peroxisomal fatty acid beta-oxidation. We also show that dhs-28, which encodes a homolog of the human d-bifunctional protein that acts just upstream of SCPx, is also required for pheromone production. Long-term daf-22 and dhs-28 cultures develop dauer-inducing activity by accumulating less active, long-chain fatty acid ascaroside derivatives. Thus, daf-22 and dhs-28 are required for the biosynthesis of the short-chain fatty acid-derived side chains of the dauer pheromone and link dauer pheromone production to metabolic state.


Related Papers